Search liu.se

Artificial Intelligence in Mammography Screening - AIM is a research program with a particular focus on clinical utility, efficiency, and implementation aspects.

Vi studerar hur fettinlagring i olika organ, så som lever, muskel och hjärta, ökar risken för sjukdomsutveckling. Förhoppningen är att kartläggning kommer att hjälpa oss att identifiera de individer som löper högst risk att utveckla sjukdom.

Cardiovascular diseases are the most common cause of death in Sweden. Anders Persson and his team have found a way to detect these diseases in time, which can ease suffering and save money.

CircM is a strategic research network for researchers at Linköping University and Region Östergötland within the research field circulation and cardio-metabolic risk factors.

Analysing the heart ads an extra dimension to the imaging since it is in constant motion. The project is working on optimizing the accuracy, measurement time, and robustness of 4D flow MRI for clinical use in the near future.

EPSONIP explores the link between fatty liver, epicardial fat and cardiovascular disease in type 2 diabetes.

Snus users who stopped using snus experienced higher blood pressure and gained weight. This has been shown by a research group at Linköping University in a study on 33 people.

Researchers at LiU have developed a new method for rapid and safe diagnosis of cardiovascular diseases. Once fully developed, the method will be able to save lives, reduce suffering and save money worldwide.

Researchers have mapped radioactivity in the marine environment at a nuclear research facility. The research has resulted in maps, that can be used to assess the risks in connection with releases of radioactive substances into the environment.

Metabolic dysfunction-associated steatotic liver disease (MASLD) previously known as non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease which has become the most common liver disease affecting adults and children.